About the Product

Description


Cardistep 25 Tablet containing Carvedilol is used for the management of hypertension, heart failure, and other cardiac conditions. It helps in improving heart function and controlling blood pressure effectively.

Carvedilol works as a beta-blocker with vasodilating properties, which helps reduce heart workload, improve blood circulation, and lower blood pressure.

The tablet is widely prescribed in cardiology practice for long-term management of cardiovascular disorders, leading to consistent demand and repeat usage.

With increasing prevalence of hypertension and heart diseases, this product offers strong business potential for retailers and distributors. Its long-term therapy requirement, steady prescription demand, and broad clinical acceptance make it a reliable product for consistent sales and growth in the cardiac segment.

Some patients may experience dizziness, fatigue, low blood pressure, slow heart rate, or nausea. Rarely, breathing difficulty, worsening heart failure symptoms, or severe allergic reactions may occur and require medical attention.

Cardistep 25 Tablet is indicated for the treatment of hypertension, chronic heart failure, and left ventricular dysfunction following myocardial infarction. It helps lower blood pressure, improve heart pumping efficiency, reduce strain on the heart, and decrease the risk of cardiovascular complications.

This medicine should be used under medical supervision. Sudden discontinuation should be avoided, as it may worsen heart conditions. Patients with asthma, diabetes, or liver disorders should use it cautiously and follow regular monitoring as advised.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Cardistep 25 Tablet in the PCD pharma franchise market?

Cardistep 25 Tablet, containing Carvedilol 25mg, has strong demand in the cardiology segment, making it a stable and high-volume product for medical distributors, wholesalers, and pharma franchise partners focusing on cardiac and chronic disease management portfolios.

Why should medical distributors include Cardistep 25 Tablet in their product range?

Medical distributors and agencies can benefit from the consistent demand for beta-blockers used in hypertension, heart failure, post-myocardial infarction management, and long-term cardiac care. Cardistep 25 Tablet helps strengthen a comprehensive cardiology product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Cardistep 25 Tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Cardistep 25 Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for Cardistep 25 Tablet distribution?

Wholesalers and medical agencies benefit from steady cardiac prescription demand, reliable supply chain support, good margins, and professional assistance when partnering for Cardistep 25 Tablet distribution.

How can I become a distributor or franchise partner for Cardistep 25 Tablet?

Medical distributors, stockists, and wholesalers interested in Cardistep 25 Tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.